has invited you to join this group
Molecular Pathologist at the University of Washington
Director of the Drug Development Unit, and Head of the Prostate Cancer Targeted Therapy Group at The Institute of Cancer Research
Assistant Professor of Medicine at Weill Cornell Medical College
Clinical Cancer Geneticist at Memorial Sloan Kettering
Professor of Urology at Northwestern University Feinberg School of Medicine
Assistant Professor of Urology and Population Health at NYU School of Medicine
Head of the Cancer Genomics and Genetics Program at Peter MacCallum Cancer Centre
Associate Professor of Epidemiology; Head, Cancer Epidemiology Track at Harvard T.H. Chan School of Public Health
Resident Physician at Beth Israel Deaconess Medical Center
A comprehensive review of the literature by Loeb et al. has highlighted varying rates of over-diagnosis and over-treatment of prostate cancer (European Eurology 2014). Can the authors and experts speak generally on this issue in the prostate cancer setting and also provide insights on how our current study of discussion will fit in the context of this wider clinical problem?
Log in or create an account to comment
Social Login
Email Login
Log in via Email
Back to Social Login
Create Your Account